Details for New Drug Application (NDA): 081240
✉ Email this page to a colleague
NDA 081240 describes CYCRIN, which is a drug marketed by Esi and is included in three NDAs. Additional details are available on the CYCRIN profile page.
The generic ingredient in CYCRIN is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
The generic ingredient in CYCRIN is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 081240
| Tradename: | CYCRIN |
| Applicant: | Esi |
| Ingredient: | medroxyprogesterone acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 081240
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Oct 30, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
